血小板源生长因子受体介导的信号转导在自发性高血压大鼠心肌肥大中的作用

为了探索血小板源生长因子 (platelet derivedgrowthfactor,PDGF)受体介导的信号转导在自发性高血压大鼠(spontaneouslyhypertensiverats,SHR)心肌肥大中的作用 ,实验采用Westernblot法检测SHR及其对照WKY大鼠心肌PDGF受体β和细胞外信号调节激酶 (extracellularsignal regulatedkinase1/ 2 ,ERK 1/ 2 )的蛋白表达和ERK 1/ 2磷酸化水平的变化。结果显示 :4周龄SHR的收缩压、舒张压、±dp/dtmax和心肌肥大指数与同龄WKY大鼠相比均无明显差异 ,而 12周龄SHR上述指标与同龄WKY大鼠相比均明显升高 ,表明 12周SHR已发生高血压 ,心脏收缩功能代偿性增强 ,并出现心肌肥大。 4周龄SHR心肌PDGF受体 β和ERK1/ 2的磷酸化水平以及ERK 1/ 2的蛋白表达水平与同龄对照相比均无明显变化 ,12周时SHR心肌PDGF受体 β的蛋白表达较同龄WKY增加 32 77% (P <　　　　　　　　　 0 0 5 ) ,PDGF受体介导的信号转导通路的下游信号分子ERK 1/ 2的磷酸化水平较同龄WKY升高 19 6 % (P =0 0 1) ,表明ERK 1/ 2的活化增加 ,但ERK 1/ 2的蛋白表达水平尚无变化。为进一步明确PDGF受体 β在心肌细胞生长中的作用及其与ERK 1/ 2活性的关系 ,采用PDGF BB刺激培养的乳鼠心肌细胞 ,发现 [3 H]亮氨酸掺入量明显增加 ,ERK 1/ 2的磷酸化水平明     

肾性和自发性高血压大鼠心肌肥大前后心肌Gαq/11含量的变化

目的 :探讨Gαq/11在不同原因所致心肌肥大中的变化。方法 :两肾一夹肾性高血压大鼠 (RHR)和自发性高血压大鼠(SHR)模型 ,测定动脉血压和心肌肥大指数 ,放免法测定心肌血管紧张素II(AngII)含量 ,免疫印迹法测定心肌Gαq/11含量。 结果 :RHR术后 1周动脉血压、心肌肥大指数及Gαq/11含量与假手术组无差异 ,心肌AngII含量显著升高 (P <0 .0 1) ;术后 8周上述各指标均较假手术组升高。 12周龄SHR动脉血压、心肌肥大指数和AngⅡ含量均较同龄WKY升高 (P均 <0 .0 1) ,但心肌Gαq/11含量却无明显变化 ;4周龄时上述各指标与同龄对照相比均无明显差异。 结论 :Gαq/11在肾性和自发性高血压心肌肥大中有不同变化。     

压力超负荷心肌肥大晚期和心衰大鼠心肌力学及Ca2+反应性的改变

目的 :观测比较肥大心肌和衰竭心肌在基础力学性能、[Ca2 ]o 正性变力作用和Ca2 通道阻滞剂负性变力作用三方面的变化和差别。方法 :大鼠升主动脉缩窄法建立左心室肥大 (LVH)和充血性心衰 (CHF)模型 ,记录离体灌流乳头肌的长度 张力曲线 ,比较基础状态和nifidipine处理后 [Ca2 ]o 与峰张力的量效关系。结果 :①CHF组长度 张力曲线较LVH组和假手术对照组 (Sham)明显下移 ;基础状态下 ([Ca2 ]o=0 .5mmo1/L) ,LVH等长收缩峰张力 (PT)尚能维持 ,但CHF组PT分别低于LVH组和Sham组 37.9%和 43 .7% (P均 <0 .0 1) ;±dT/dtmax也较LVH组进一步下降 (P <0 .0 1) ;②各组峰张力随 [Ca2 ]o 的升高而增强 ,但CHF组 [Ca2 ]o 作用的量效曲线较LVH和Sham明显下移 ;③nifedjpine的负性肌力作用具明显剂量依赖性 ,但其抑制程度在三组间没有明显差异 (P>0 .0 5 )。结论 :肥大心肌以收缩强度不变区别于衰竭心肌的收缩低抑。两组收缩速度、舒张速率和 [Ca2 ]o 正变力效应的下降程度递增 ,但Ca2 通道阻滞剂的负变力效应均无改变。     

肾性高血压大鼠肥大心肌的力速关系和收缩末期张力长度关系

左肾动脉部分狭窄造成大鼠肾血管性高血压,研究高血压四周肥大心肌的力速关系,收缩末期张力长度关系(ESTLR)以及对细胞外高钙的反应。结果表明:(1)肥大心肌主动峰张力 PT 轻度增大,零负荷最大缩短速度 V_(max)明显减小,收缩时程 TPT 延长(P<0.01),力速曲线向下移位;(2)高血压组心肌 ESTLR 与对照相似,亦为非线性的指数曲线。回归参数a(总张力)、k(静息张力)、b(曲线曲率)和 L。(最大缩短程度)均无明显改变(P>0.05),(3)高钙灌流时,肥大心肌的反应(△PT,△V_(max)和△TPT)与对照间无显著差异(P>0.05)。上述结果提示:高血压心肌肥大早期基础力学性能的变化以力速分离现象为特征,此时心肌功能的异常可能与肌膜钙转运系统的功能状态无关;对于心肌收缩能力的这种慢性改变,心肌力学指标比 ESTLR 类参数更敏感。     

自发性高血压大鼠中枢5－HT_（1A）受体的特性

本文用放射性配基［３Ｈ］８－ＯＨ－ＤＰＡＴ的结合实验显示,自发性高血大鼠（ＳＨＲ）海马、下丘脑及低位脑干的５－ＨＴ１Ａ受体结合位点数较正常Ｗｉｓｔａｒ大鼠为多,其中以海马最为显著;脑干的５－ＨＴ１Ａ受体虽较正常Ｗｉｓｔａｒ大鼠多,但不太明显。ＳＨＲ下丘脑中５－ＨＴ１Ａ受体除结合位点较正常Ｗｉｓｔａｒ鼠多外,亲和力也有增大。以上结果表明,ＳＨＲ与正常Ｗｉｓｔａｒ大鼠之间各脑区中５－ＨＴ１Ａ受体的差别可能与高血压病的发生有关。     

肾血管性高血压大鼠发病过程中心血管AT1-受体自身抗体的变化

实验观察了肾血管性高血压（RVH）大鼠血浆中抗AT1－受体自身抗体在发病过程中的作用及其变化规律。采用两肾一夹Goldblatt RVH模型,以合成的大鼠AT1－受体细胞外第二环165－191位氨基酸序列作为特慢性抗原,用SA－ELISA法检测大鼠血清中抗AT1-受体自身抗体。结果表明,RVH模型组术后2周时大鼠血清中抗AT1－受体自身抗体的阳性率和平均滴度与术前相比明显增高,较高的阳性率和平均滴度持续几周后逐渐下降,12周时下降到正常水平。结果提示,自身免疫机制参与了高血压的形成,抗AT1－受体自身抗体可能与心肌肥厚有关。     

Chronic low-dose treatment with enalapril induced cardiac regression of left ventricular hypertrophy

Molecular and Cellular Biochemistry - Numerous studies suggest that the renin angiotensin system (RAS) is involved in the development of cardiac hypertrophy. In the present study we produced...     

Effects of regression of cardiac hypertrophy on myocardial contractility and ventricular myosin isoenzymes

The effects of regression of cardiac hypertrophy on myocardial contractility and ventricular myosin isoenzymes were investigated in rats with renovascular hypertension. Six-week-old male Wistar rats were made hypertensive by constriction of one renal artery with a silver clip. Regression of cardiac hypertrophy was induced following the lowering of blood pressure by nephrectomy on the affected side 5–6 weeks after constriction of the renal artery and was maintained for 5–6 weeks. In contrast, myocardial hypertrophy was induced by 10–11 weeks of the hypertensive state. Isometric developed tension of isolated left ventricular papillary muscles was measured, while they were being perfused with Tyrode solution. Left ventricular myosin isoenzymes were separated by pyrophosphate gel electrophoresis. The ventricular to body weight ratio of the nephrectomized group was significantly lower than that of the hypertensive group, although it was greater than that of age-matched normal control rats. There were no significant differences in the isometric developed tension among three groups, the nephrectomized, hypertensive, and normal control rats. However, dT/dtmax tended to decrease in the hypertensive rats and recovered to normal in the nephrectomized rats. The left ventricular myosin isoenzyme pattern was shifted toward VM-3 in hypertensive rats and was shifted back toward VM-1 again in nephrectomized rats.     

Effect of angiotensin coverting enzyme inhibitor on regression in cardiac hypertrophy

Cardiac hypertrophy in rats was produced by aortic banding for 6 weeks and regression of hypertrophy in these experimental animals was induced by administration of angiotensin converting enzyme inhibitor, enalapril (10 mg/kg/ day) for 6 weeks. The left ventricular muscle mass and systolic pressure were decrease upon treating the hypertrophied rats with enalapril. This drug also decreased the number of 1-adrenoceptors in hypertrophyied myocardium without any changes in -adrenoceptors. The regression of cardiac hypertrophy in spontaneously hypertensive rats by enalapril for 10 weeks was not associated with any alterations in 1-adrenoceptors in hypertrophied myocardium, but was decreased in -adrenoceptors. Effects of enalapril on extracellular matrix in the myocardium was also observed in regression of hypertrophy in which the type III collagen mRNA expression and collagen contents were reduced in comparison with those of hypertrophied myocardium. These results indicate that regression of cardiac hypertrophy is not alway associated with a decrease in the number of 1-adrenergic receptors and that the beneficial effects of enalapril in the hypertrophied heart in aortic banding animals may be of some specific nature.     

左肾动脉缩窄诱导心肌肥大大鼠心肌蛋白差异表达研究

目的：应用蛋白质组学方法分析病理性心肌肥大心肌细胞蛋白表达特征。方法：雄性SD大鼠16只,分为2组（n=8）：两肾一夹组（2K1C）和假手术组（SO）,术后饲养8周,使用普通多普勒和组织多普勒鉴定动物模型,然后提取心肌总蛋白,应用二维凝胶电泳技术,建立分辨率高和重复性良好的凝胶图像,质谱（MALDI—TOF-MS）鉴定差异蛋白点,与网络数据库进行匹配,并对鉴定蛋白进行分类。结果：两肾一夹大鼠心肌细胞有21个蛋白点表现出显著增加或减少,经数据库匹配,获得14种差异表达的蛋白质。结论：两肾一夹大鼠心肌出现一些差异表达蛋白席官们可能在病理性心肌肥大的发生中起重要作用。     

大鼠不同心肌肥厚模型左心室基因表达谱变化的比较

为了解心肌肥厚时基因表达谱的变化规律,本实验复制了三种大鼠心肌肥厚模型：肾上腹主动脉缩窄(suprarenal abdominal aortic stenosis,SRS)、动静脉瘘(arterial-vein fistula,AVF)和去甲。肾上腺素持续静脉输注(jugular vein infusion of norepinephrine,NEi),并应用组织化学方法和超声心动术检测大鼠心脏结构和功能指标,应用cDNA基因芯片技术检测心脏基因表达水平的变化。SRS和NEi引起大鼠向心性心肌肥厚,AVF引起大鼠离心性心肌肥厚,其中NEi大鼠心肌纤维化明显。对不同心肌肥厚模型间大鼠左心室基因表达谱的变化进行两两比较。结果显示,有部分基因在不同模型中表达水平均发生变化,其中多数基因在两种模型中表达水平改变的方向相同,也有少部分基因在两种模型中表达水平改变方向相反。综合比较三种心肌肥厚模型的基因表达谱,各种模型都有特异的基因表达变化,但是有19个基因在三种心肌肥厚模型中表达水平均发生改变。研究结果有可能成为心肌肥厚的标志性基因或治疗靶点,为心肌肥厚发生机制的深入研究提供了新的线索。     

Agiotensin II induced cardiac hypertrophy in vivo is inhibited by cyclosporin A in adult rats

Recently, the calciumcalmodulindependent calcineurin pathway has been defined as a central pathway for the induction of cardiac hypertrophy. The purpose of this study was to determine if cardiac hypertrophy in animals chronically treated with angiotensin II (AngII), could be prevented by blocking this pathway with cyclosporin A (CsA). Female Wistar rats were treated with AngII by subcutaneous infusion and injected twice a day with CsA (25 mg/kg) for 7 days. In the AngII treated group there was a 30% increase in the heart/body weight ratio (p < 0.05 vs. control). The increase in heart weight was blocked with CsA. Substantial increases in ANF and MHC gene expression were detected in the AngII treated animals, which were either attenuated or blocked with CsA treatment. Thus, this study demonstrates that CsA does prevent the development of cardiac hypertrophy in Ang II treated rats, suggesting that the calciumcalmodulindependent calcineurin pathway is associated with angiotensin II induced hypertrophy in vivo.     

Role of cardiac renin-angiotensin system in the development of pressure-overload left ventricular hypertrophy in rats with abdominal aortic constriction

Possible involvement of cardiac renin-angiotensin system (RAS) in pressure overload induced left ventricular hypertrophy (LVH) was investigated. Rats were subjected to abdominal aortic constriction (AAC) and examined the effects of 4 weeks treatments with an angiotensin converting enzyme (ACE) inhibitor, captopril and a vasodilator, hydralazine on haemodynamics and ventricular RNA, DNA, protein and myosin isoform pattern in sham and hypertrophied rats. AAC increased the mean arterial pressure (MAP) and systolic blood pressure (SBP), and resulted in increased left ventricle/body weight ratio, LV thickness, RNA and protein content, however total DNA was not changed. The expression of fetal isogene, -myosin heavy chain (-MHC), was markedly enhanced where as u.-MHC was reduced. High-dose captopril (100 mg/kg p.o.,) significantly prevented the increase in haemodynamics, development of LVH, LV remodeling, increase in total protein, RNA and antithetical expression of myosin isoforms. Hydralazine (15 mg/kg p.o.,), did not modulate hypertrophic changes and low-dose captopril (1.5 mg/kg p.o.,) which has not produced any marked fall in MAP and SBP also modulated favourably the development of LVH and its biochemical markers. Thus, the prevention of the development of LVH and induction of -MHC by non-hypotensive doses of captopril may be related to the blockade of intracardiac production of angiotensin II rather than circulating system. These results suggest that cardiac RAS may play an important role in pressure overload induced LVH.     

小鼠心肌肥厚发展过程中心电图动态变化

目的：探讨小鼠心肌肥厚发展过程中心电图的动态变化。方法：复制小鼠压力超负荷性心肌肥厚模型,连续动态监测小鼠从心肌肥厚早期至心力衰竭发展过程中的不同阶段体表心电图改变。结果：①对照组和模型组术后2周内小鼠未见自发性心律失常,而模型组术后5周、9周和13周小鼠出现自发性心律失常,主要表现为频发的室性早搏以及阵发性室性心动过速,心律失常发生率分别为15％、28％和63％。②与同期对照相比,术后2周、5周、9周和13周组动物伽间期以及帆间期明显延长,分别延长20．4％、32．7％、49．7％、61．0％和27．1％、32．1％、43．9％、59．1％（P〈0．01）。③心肌肥厚小鼠心电图的另一个特征为J波变化。所有对照组动物心电图均为正向J波,而模型组动物从2周开始J波正向值下降,5周逐渐变平,到13周时完全翻转。④与同期对照相比,模型组的PR间期没有改变,但术后2周RR问期轻微缩短。结论：心肌肥厚小鼠自发性心律失常发生率逐渐增加,QT间期进行性延长,J波幅值逐渐降低,表明随着疾病的进展心室复极化异常逐渐加重。     

慢性低氧对大鼠左右心室的功能及TRPC亚家族表达的影响

目的：探讨慢性低氧3周对大鼠左右心室的影响以及规范性瞬时感受器电位亚家族（TRPC）在慢性低氧诱导的右心室心肌肥厚中的表达。方法：将SD雄性大鼠48只随机分为对照组（CON组）和慢性低氧肺动脉高压模型组（CH组）（n=24）,CH组将大鼠置于连续的慢性低氧（10％±0．2％）环境饲养三周以诱导大鼠发生心肌肥厚。通过左、右心室插管法测定右心室内压（RVSP）、左心室内压（LVSP）、心率（HR）、平均体循环动脉压（mSAP）、左、右心室内压力最大上升速率（＋dp／dtmax）、最大下降速率（-dp／dkmax）、右心肥大指数（RVMI）、左心肥大指数（LVMI）;HE染色观察左、右心室心肌组织切片;通过SYBR Green荧光定量PCR法检测CON组、CH组大鼠的肥厚侧心室心肌组织编码TRPC 1／3／4／5／6／7的rnRNA表达;结合real-time RT-PCR结果对mRNA表达有显著变化的TRPC亚型通过免疫印迹法检测相应蛋白的表达。结果：与CON组相比：CH组的RVSP、RVMI、右心室±dp／dtmax显著增高（P〈0．01）,LVSP、左心室±dp／dmax无显著变化,LVMI显著降低（P〈0．01）;CH组右心室心肌细胞显著增粗（P〈0．01）,细胞内肌原纤维数量增多,心肌纤维排列紊乱,细胞核深染,形状不整;左心室心肌纤维无明显改变;CH组编码TRPCI的mRNA和蛋白显著增高（P〈0．05）,而编码其余TRPC亚型的mRNA无显著变化。结论：慢性低氧3周可特异性诱导sD大鼠产生右心室心肌肥厚,上调了编码右心室心肌细胞TRPCI通道蛋白的mRNA和蛋白的表达,TRPCI可能参与了心肌肥厚的发生发展。     

法舒地尔对异丙肾上腺素诱导大鼠心肌肥厚的干预作用及其机制

目的：研究法舒地尔对异丙肾上腺素诱导大鼠心肌肥厚的影响及其机制。方法：除正常对照组外,其它SD大鼠均皮下注射异丙肾上腺素（Iso,5 mg/kg）建立心肌肥厚模型。大鼠随机分为4组：正常对照组、Iso模型组、法舒地尔低剂量组（Fas,5 mg/kg,i.p）和法舒地尔高剂量组（Fas,20 mg/kg,i.p）,连续给药8周。给药结束后,血流动力学检测大鼠心率（HR）、左心室收缩压（LVSP）、左心室末舒张压（LVEDP）和左室压力变化最大速率（±dp/dt_max）;分别测定大鼠体重（BW）,心脏重量（HW）,并计算HW/BW;大鼠心肌HE、Masson染色观察组织病理学改变;免疫组化法观察大鼠心肌组织ERK1、ERK2蛋白表达,RT-PCR观察ERK1、ERK2 mRNA的表达。结果：Iso模型组HR和LVEDP明显升高,LVSP和±dp/dt_max明显下降;HW/BW增大;心肌细胞体积变大,排列紊乱,胶原纤维增生;左心室组织ERK1、ERK2蛋白与mRNA表达上调。法舒地尔不同剂量干预后,心脏收缩和舒张能力得到改善,心指数明显下降,心肌细胞体积变小,纤维化减少,ERK1/2 mRNA表达下调,心肌组织损害均得到不同程度改善。结论：ERK1/2信号通路活化参与了异丙肾上腺素诱导的心肌肥厚,法舒地尔对异丙肾上腺素诱导的心肌肥厚具有明显改善作用,这可能与法舒地尔阻断ERK1、ERK2通路活化有关。